324 related articles for article (PubMed ID: 34954690)
21. A novel immune-related lncRNA signature predicts the prognosis and immune landscape in ccRCC.
Dai L; Pan D; Jin J; Lv W
Aging (Albany NY); 2024 Mar; 16(6):5149-5162. PubMed ID: 38484738
[TBL] [Abstract][Full Text] [Related]
22. Accurate prognostic prediction for patients with clear cell renal cell carcinoma using a ferroptosis-related long non-coding RNA risk model.
Xiang X; Guo Y; Chen Z; Zhang F; Qin Y
Cancer Biomark; 2023; 37(2):95-107. PubMed ID: 37248883
[TBL] [Abstract][Full Text] [Related]
23. Disulfideptosis-associated lncRNAs reveal features of prognostic, immune escape, tumor mutation, and tumor malignant progression in renal clear cell carcinoma.
Li X; Deng X; Liu T; Zhang W; Tao J
Aging (Albany NY); 2024 Feb; 16(4):3280-3301. PubMed ID: 38334964
[TBL] [Abstract][Full Text] [Related]
24. Identification of a competing endogenous RNA network related to immune signature in clear cell renal cell carcinoma.
Zhang Y; Dai J; Huang W; Chen Q; Chen W; He Q; Chen F; Zhang P
Aging (Albany NY); 2021 Dec; 13(24):25980-26002. PubMed ID: 34958632
[TBL] [Abstract][Full Text] [Related]
25. Selection of M7G-related lncRNAs in kidney renal clear cell carcinoma and their putative diagnostic and prognostic role.
Zhong S; Chen S; Lin H; Luo Y; He J
BMC Urol; 2023 Nov; 23(1):186. PubMed ID: 37968670
[TBL] [Abstract][Full Text] [Related]
26. Integrated analysis of long noncoding RNA associated-competing endogenous RNA as prognostic biomarkers in clear cell renal carcinoma.
Yin H; Wang X; Zhang X; Wang Y; Zeng Y; Xiong Y; Li T; Lin R; Zhou Q; Ling H; Zhou F; Zhou Y
Cancer Sci; 2018 Oct; 109(10):3336-3349. PubMed ID: 30152187
[TBL] [Abstract][Full Text] [Related]
27. Construction and Validation of a Novel Cuproptosis-Related Seven-lncRNA Signature to Predict the Outcomes, Immunotherapeutic Responses, and Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma.
Zhang H; Ning Z; Wang B; Liu Y; Tao B; Zhang G; Liu H; Wang C
Dis Markers; 2023; 2023():7219794. PubMed ID: 36741910
[TBL] [Abstract][Full Text] [Related]
28. A novel autophagy-related long non-coding RNAs prognostic risk score for clear cell renal cell carcinoma.
Tang F; Tang Z; Lu Z; Cai Y; Lai Y; Mai Y; Li Z; Lu Z; Zhang J; Li Z; He Z
BMC Urol; 2022 Dec; 22(1):203. PubMed ID: 36496360
[TBL] [Abstract][Full Text] [Related]
29. Investigating the prognostic role of lncRNAs associated with disulfidptosis-related genes in clear cell renal cell carcinoma.
Sun Z; Wang J; Fan Z; Yang Y; Meng X; Ma Z; Niu J; Guo R; Tran LJ; Zhang J; Jiang T; Liu Y; Yang Q; Ma B
J Gene Med; 2024 Jan; 26(1):e3608. PubMed ID: 37897262
[TBL] [Abstract][Full Text] [Related]
30. Key sunitinib-related biomarkers for renal cell carcinoma.
Peng Y; Dong S; Song Y; Hou D; Wang L; Li B; Wang H
Cancer Med; 2021 Oct; 10(19):6917-6930. PubMed ID: 34402193
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of CCNB2 and a novel lncRNAs-related risk model predict prognosis in clear cell renal cell carcinoma.
Ren C; Wang Q; Xu Z; Pan Y; Wang S; Liu X
J Cancer Res Clin Oncol; 2024 Feb; 150(2):64. PubMed ID: 38300330
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of long non-coding RNA ENSG00000241684 is associated with poor prognosis in advanced clear cell renal cell carcinoma.
Su H; Wang H; Shi G; Zhang H; Sun F; Ye D
Eur J Surg Oncol; 2018 Jun; 44(6):840-846. PubMed ID: 29433989
[TBL] [Abstract][Full Text] [Related]
33. Effect of Aberrant Long Noncoding RNA on the Prognosis of Clear Cell Renal Cell Carcinoma.
Wu H; Wu H; Sun P; Zhu D; Ma M; Fan W
Comput Math Methods Med; 2021; 2021():6533049. PubMed ID: 34512796
[TBL] [Abstract][Full Text] [Related]
34. Identification of exosomes-related lncRNAs in clear cell renal cell carcinoma based on Bayesian spike-and-slab lasso approach.
Niu Y; Jia X; Wang N; Yuan M; Dong A; Yang Y; Shi X
Funct Integr Genomics; 2023 Feb; 23(1):62. PubMed ID: 36805328
[TBL] [Abstract][Full Text] [Related]
35. A novel necroptosis-related lncRNAs signature for survival prediction in clear cell renal cell carcinoma.
Zhao L; Luo H; Dong X; Zeng Z; Zhang J; Yi Y; Lin C
Medicine (Baltimore); 2022 Sep; 101(39):e30621. PubMed ID: 36181033
[TBL] [Abstract][Full Text] [Related]
36. Molecular subtypes of clear cell renal carcinoma based on PCD-related long non-coding RNAs expression: insights into the underlying mechanisms and therapeutic strategies.
Wang H; Liu Y; Tang A; Zhang X
Eur J Med Res; 2024 May; 29(1):292. PubMed ID: 38773560
[TBL] [Abstract][Full Text] [Related]
37. Identification of Six Potentially Long Noncoding RNAs as Biomarkers Involved Competitive Endogenous RNA in Clear Cell Renal Cell Carcinoma.
Yang K; Lu XF; Luo PC; Zhang J
Biomed Res Int; 2018; 2018():9303486. PubMed ID: 30406146
[No Abstract] [Full Text] [Related]
38. A long non-coding RNA signature to improve prognostic prediction in clear cell renal cell carcinoma.
Zhang J; Zhang X; Piao C; Bi J; Zhang Z; Li Z; Kong C
Biomed Pharmacother; 2019 Oct; 118():109079. PubMed ID: 31351427
[TBL] [Abstract][Full Text] [Related]
39. A Risk Score Model Based on Nine Differentially Methylated mRNAs for Predicting Prognosis of Patients with Clear Cell Renal Cell Carcinoma.
Zhou J; Liu G; Wu X; Zhou Z; Li J; Ji Z
Dis Markers; 2021; 2021():8863799. PubMed ID: 33510822
[TBL] [Abstract][Full Text] [Related]
40. The Expression and Prognostic Value of Co-stimulatory Molecules in Clear Cell Renal Cell Carcinoma (CcRcc).
Wu C; Cai X; He C
Comb Chem High Throughput Screen; 2024; 27(2):335-345. PubMed ID: 37171001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
